Literature DB >> 9160965

Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions.

W Rostene1, M Azzi, H Boudin, I Lepee, F Souaze, M Mendez-Ubach, C Betancur, D Gully.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9160965     DOI: 10.1111/j.1749-6632.1997.tb46151.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.

Authors:  Yanli Zhang; Shunqin Zhu; Liang Yi; Yaling Liu; Hongjuan Cui
Journal:  Mol Cell Biochem       Date:  2013-12-20       Impact factor: 3.396

2.  Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.

Authors:  E B Binder; B Kinkead; M J Owens; C D Kilts; C B Nemeroff
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

3.  Constitutive activation of the neurotensin receptor 1 by mutation of Phe(358) in Helix seven.

Authors:  Séverine Barroso; Françoise Richard; Delphine Nicolas-Ethève; Patrick Kitabgi; Catherine Labbé-Jullié
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

4.  Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference.

Authors:  Klara Felszeghy; José Manuel Espinosa; Hélène Scarna; Anne Bérod; William Rostène; Didier Pélaprat
Journal:  Neuropsychopharmacology       Date:  2007-03-14       Impact factor: 7.853

5.  Targeting neurotensin as a potential novel approach for the treatment of autism.

Authors:  Ahmad Ghanizadeh
Journal:  J Neuroinflammation       Date:  2010-10-01       Impact factor: 8.322

6.  Neurotensin effect on Na+, K+-ATPase is CNS area- and membrane-dependent and involves high affinity NT1 receptor.

Authors:  María Graciela López Ordieres; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.